1 option
GlaxoSmithKline : executive compensation and a shareholder revolt / John C. Eklund, Scott A. Frymoyer, E. Kaleo Yamabayshi, James S. O'Rourke.
- Format:
- Book
- Author/Creator:
- Eklund, John C., author.
- Frymoyer, Scott A., author.
- Yamabayshi, E. Kaleo, author.
- O'Rourke, James S., IV, 1946- author.
- Series:
- SAGE Knowledge. Cases.
- SAGE Knowledge. Cases
- Language:
- English
- Subjects (All):
- GlaxoSmithKline.
- Pharmaceutical industry--Public relations.
- Pharmaceutical industry.
- Employee stock options.
- Physical Description:
- 1 online resource : illustrations.
- Place of Publication:
- London : SAGE Publications Ltd, 2017.
- Summary:
- A series of controversies and market reversals begin to affect one of the worlds largest pharmaceutical firms. As share price tumbles and market share erodes, CEO J.P. Garnier is awarded a very large compensation package early in 2003. Shareholders revolt, voting down the executive compensation package, and threaten to take down the management team. GSK Chairman Lord Christopher Hogg and Communications VP Jennie Younger must decide how to proceed in the face of mounting criticism and public outrage.
- Notes:
- Originally published: Eklund, J. C., Frymoyer, S. A., Yamabayshi, E. K., & ORourke, J. S. (2004). GlaxoSmithKline: Executive compensation and a shareholder result. 04-02. Notre Dame, IN: The Eugene D. Fanning Center for Business Communication, Mendoza College of Business, University of Notre Dame.
- Description based on XML content.
- ISBN:
- 1-5264-0613-6
- 9781526406132
- OCLC:
- 1017713795
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.